SQNM Hits 6 Year High Then Retreats To $14.40

Sequenom Inc (NasdaqGM: SQNM) hit is 6 year high of $15.25 on Friday and continues to thrive in the market on expectations that the company has developed what will soon become the standard test for Down syndrome.

I first mentioned this company at a price of $9.33 on 6/4. Since then we have seen shares run up nearly 65% on much higher volume than in the weeks prior.

SQNM pulled back a bit today to $14.40 on nearly 2 million shares traded after bouncing off of an intra-day low of $13.89.

Here is another good read on Down Syndrome testing: